Literature DB >> 18086840

Human macrophage inflammatory protein 3alpha: protein and peptide nuclear magnetic resonance solution structures, dimerization, dynamics, and anti-infective properties.

David I Chan1, Howard N Hunter, Brian F Tack, Hans J Vogel.   

Abstract

Human macrophage inflammatory protein 3alpha (MIP-3alpha), also known as CCL20, is a 70-amino-acid chemokine which exclusively binds to chemokine receptor 6. In addition, the protein also has direct antimicrobial, antifungal, and antiviral activities. The solution structure of MIP-3alpha was solved by the use of two-dimensional homonuclear proton nuclear magnetic resonance (NMR). The structure reveals the characteristic chemokine fold, with three antiparallel beta strands followed by a C-terminal alpha helix. In contrast to the crystal structures of MIP-3alpha, the solution structure was found to be monomeric. Another difference between the NMR and crystal structures lies in the angle of the alpha helix with respect to the beta strands, which measure 69 and approximately 56.5 degrees in the two structures, respectively. NMR diffusion and pH titration studies revealed a distinct tendency for MIP-3alpha to form dimers at neutral pH and monomers at lower pH, dependent on the protonation state of His40. Molecular dynamics simulations of both the monomeric and the dimeric forms of MIP-3alpha supported the notion that the chemokine undergoes a change in helix angle upon dimerization and also highlighted the important hydrophobic and hydrogen bonding contacts made by His40 in the dimer interface. Moreover, a constrained N terminus and a smaller binding groove were observed in dimeric MIP-3alpha simulations, which could explain why monomeric MIP-3alpha may be more adept at receptor binding and activation. The solution structure of a synthetic peptide consisting of the last 20 residues of MIP-3alpha displayed a highly amphipathic alpha helix, reminiscent of various antimicrobial peptides. Antimicrobial assays with this peptide revealed strong and moderate bactericidal activities against Escherichia coli and Staphylococcus aureus, respectively. This confirms that the C-terminal alpha-helical region of MIP-3alpha plays a significant part in its broad anti-infective activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18086840      PMCID: PMC2258517          DOI: 10.1128/AAC.00805-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  63 in total

1.  Detection and localization of Mip-3alpha/LARC/Exodus, a macrophage proinflammatory chemokine, and its CCR6 receptor in human pancreatic cancer.

Authors:  J Kleeff; T Kusama; D L Rossi; T Ishiwata; H Maruyama; H Friess; M W Büchler; A Zlotnik; M Korc
Journal:  Int J Cancer       Date:  1999-05-17       Impact factor: 7.396

2.  Alpha-lactalbumin forms a compact molten globule in the absence of disulfide bonds.

Authors:  C Redfield; B A Schulman; M A Milhollen; P S Kim; C M Dobson
Journal:  Nat Struct Biol       Date:  1999-10

3.  Identification of surface residues of the monocyte chemotactic protein 1 that affect signaling through the receptor CCR2.

Authors:  K Jarnagin; D Grunberger; M Mulkins; B Wong; S Hemmerich; C Paavola; A Bloom; S Bhakta; F Diehl; R Freedman; D McCarley; I Polsky; A Ping-Tsou; A Kosaka; T M Handel
Journal:  Biochemistry       Date:  1999-12-07       Impact factor: 3.162

4.  Structure of human MIP-3alpha chemokine.

Authors:  Zulfiqar A Malik; Brian F Tack
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-06-30

5.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

6.  Novel antiviral activity of chemokines.

Authors:  Takashi Nakayama; Jumi Shirane; Kunio Hieshima; Michiko Shibano; Masayasu Watanabe; Zhe Jin; Daisuke Nagakubo; Takuya Saito; Yoshikazu Shimomura; Osamu Yoshie
Journal:  Virology       Date:  2006-04-17       Impact factor: 3.616

7.  Glycosaminoglycans mediate cell surface oligomerization of chemokines.

Authors:  A J Hoogewerf; G S Kuschert; A E Proudfoot; F Borlat; I Clark-Lewis; C A Power; T N Wells
Journal:  Biochemistry       Date:  1997-11-04       Impact factor: 3.162

Review 8.  Chemokine: receptor structure, interactions, and antagonism.

Authors:  Samantha J Allen; Susan E Crown; Tracy M Handel
Journal:  Annu Rev Immunol       Date:  2007       Impact factor: 28.527

9.  The structure of human macrophage inflammatory protein-3alpha /CCL20. Linking antimicrobial and CC chemokine receptor-6-binding activities with human beta-defensins.

Authors:  David M Hoover; Cyril Boulegue; De Yang; Joost J Oppenheim; Kenneth Tucker; Wuyuan Lu; Jacek Lubkowski
Journal:  J Biol Chem       Date:  2002-07-30       Impact factor: 5.157

10.  Many chemokines including CCL20/MIP-3alpha display antimicrobial activity.

Authors:  De Yang; Qian Chen; David M Hoover; Patricia Staley; Kenneth D Tucker; Jacek Lubkowski; Joost J Oppenheim
Journal:  J Leukoc Biol       Date:  2003-09       Impact factor: 4.962

View more
  13 in total

1.  Many Roles of CCL20: Emphasis on Breast Cancer.

Authors:  Kingsley O Osuala; Bonnie F Sloane
Journal:  Postdoc J       Date:  2014-03

2.  EGFR and IL-1 signaling synergistically promote keratinocyte antimicrobial defenses in a differentiation-dependent manner.

Authors:  Andrew Johnston; Johann E Gudjonsson; Abhishek Aphale; Andrew M Guzman; Stefan W Stoll; James T Elder
Journal:  J Invest Dermatol       Date:  2010-10-21       Impact factor: 8.551

3.  Native thrombocidin-1 and unfolded thrombocidin-1 exert antimicrobial activity via distinct structural elements.

Authors:  Paulus H S Kwakman; Jeroen Krijgsveld; Leonie de Boer; Leonard T Nguyen; Laura Boszhard; Jocelyne Vreede; Henk L Dekker; Dave Speijer; Jan W Drijfhout; Anje A te Velde; Wim Crielaard; Hans J Vogel; Christina M J E Vandenbroucke-Grauls; Sebastian A J Zaat
Journal:  J Biol Chem       Date:  2011-10-24       Impact factor: 5.157

4.  Exploring platelet chemokine antimicrobial activity: nuclear magnetic resonance backbone dynamics of NAP-2 and TC-1.

Authors:  Leonard T Nguyen; Paulus H S Kwakman; David I Chan; Zhihong Liu; Leonie de Boer; Sebastian A J Zaat; Hans J Vogel
Journal:  Antimicrob Agents Chemother       Date:  2011-02-14       Impact factor: 5.191

5.  The antimicrobial activity of CCL28 is dependent on C-terminal positively-charged amino acids.

Authors:  Bin Liu; Eric Wilson
Journal:  Eur J Immunol       Date:  2010-01       Impact factor: 5.532

6.  Protein engineering of the chemokine CCL20 prevents psoriasiform dermatitis in an IL-23-dependent murine model.

Authors:  A E Getschman; Y Imai; O Larsen; F C Peterson; X Wu; M M Rosenkilde; S T Hwang; B F Volkman
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-06       Impact factor: 11.205

7.  Structural perspectives on antimicrobial chemokines.

Authors:  Leonard T Nguyen; Hans J Vogel
Journal:  Front Immunol       Date:  2012-12-28       Impact factor: 7.561

8.  Sulfotyrosine recognition as marker for druggable sites in the extracellular space.

Authors:  Joshua J Ziarek; Maxime S Heroux; Christopher T Veldkamp; Francis C Peterson; Brian F Volkman
Journal:  Int J Mol Sci       Date:  2011-06-08       Impact factor: 5.923

9.  Antimicrobial activities of chemokines: not just a side-effect?

Authors:  Marlene Wolf; Bernhard Moser
Journal:  Front Immunol       Date:  2012-07-23       Impact factor: 7.561

10.  CCL20 and Beta-Defensin 2 Production by Human Lung Epithelial Cells and Macrophages in Response to Brucella abortus Infection.

Authors:  M Soledad Hielpos; Mariana C Ferrero; Andrea G Fernández; Josefina Bonetto; Guillermo H Giambartolomei; Carlos A Fossati; Pablo C Baldi
Journal:  PLoS One       Date:  2015-10-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.